ReviewSpringerPlus2016

Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.

Cheng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.